Wegovy works by mimicking the action of a hormone called glucagon-like peptide-1 (GLP-1) in the body. It helps control appetite and reduce food intake by signaling the brain to feel full. This leads to reduced calorie intake, promoting weight loss over time.

Wegovy is typically prescribed to adults with a BMI of 30 or higher, or to those with a BMI of 27 or higher who have at least one weight-related condition (such as high blood pressure, type 2 diabetes, or high cholesterol). However, eligibility criteria may vary, and it is important to consult a healthcare provider to determine if Wegovy is suitable for an individual's specific circumstances.

Wegovy is injected once a week, on the same day each week. It is administered subcutaneously, usually in the abdomen, thigh, or upper arm. Healthcare providers will provide detailed instructions on how to properly administer the injection.

Common side effects of Wegovy may include nausea, vomiting, diarrhea, constipation, abdominal pain, and decreased appetite. These side effects often improve over time as the body adjusts to the medication. However, serious side effects such as pancreatitis or gallbladder problems are rare but possible. It is crucial to report any unusual or severe symptoms to a healthcare provider promptly.

No, Wegovy is not a substitute for a healthy diet and regular physical activity. It is intended to be used in conjunction with a reduced-calorie diet and increased physical activity for effective weight management. Individuals using Wegovy should continue to focus on making lifestyle changes to support their weight loss journey and overall well-being.